Abstract Osteoporosis can define as a major bone disease especially in older women, it correlated with decrease bone density and change in the bone structure that may be increase in bone fragility. Osteoporosis more prevalence in women with age over 50 years old (post menopause), this correlate with estrogen hormone deficiency, this bone loss may be rapid and lead to accelerate bone resorption because of lack of balance occur between osteoclast and osteoblast, increasing in the osteoblast differentiation lead to osteoporosis activation. After menopause estrogen level will decrease due to the lacking occur in eggs produced by ovaries and this will lead to increase synthesis of IL-1, IL-6 and tumor necrosis factor and OPG level will decreased and this will lead to increase bone turnover and osteoporosis, at the same time promote vascular calcification due to increase action of RANKL one bone and vascular cell. Two group included in this study divided into patient group (n=25), age 50 years and over postmenopausal women and control group (n=50), age between 30-50 years' premenopausal women. 5ml of blood was taken from both postmenopausal and premenopausal women. All blood samples for both groups was tested for calcium, alkaline phosphtase and OPG level. OPG level was determined by ELISA technique. Serum level of alkaline phosphatase was found to be higher in postmenopausal group than premenopausal women group (p<0.001). serum calcium level is lower in postmenopausal group than premenopausal women group (p<0.001). serum osteoprotegerin level was higher in postmenopausal group than premenopausal women group (p<0.001). osteoprotegerin (OPG) can be used as indicator of osteoporosis and useful for early diagnosis in postmenopausal women.
Read full abstract